Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will assess the pharmacokinetics, safety and tolerability of a single dose of
AGO178C in subjects with mild, moderate, severe renal impairment and end-stage renal disease
with that in healthy matched control subjects.